*Based on commercial patients, early access patients, and clinical trial participants through December 2019.
There’s someone from almost every age group who has been treated with SPINRAZA.
†Includes clinical trial patients.
‡Clinical studies of SPINRAZA did not include sufficient numbers of subjects aged 65 and older to determine
whether they respond differently from younger patients.
§Based on commercial patients in the US (including Puerto
Rico) through December 2019.
The most common side effects of SPINRAZA include lower respiratory infection, fever, constipation, headache, vomiting, back pain, and post-lumbar puncture syndrome. These are not all of the possible side effects of SPINRAZA.